These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19375057)

  • 1. Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation.
    Wang ZQ; Si L; Tang Q; Lin D; Fu Z; Zhang J; Cui B; Zhu Y; Kong X; Deng M; Xia Y; Xu H; Le W; Hu L; Kong X
    Am J Hum Genet; 2009 May; 84(5):672-7. PubMed ID: 19375057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage of a locus determining familial progressive hyperpigmentation (FPH) to chromosome 19p13.1-pter in a Chinese family.
    Zhang C; Deng Y; Chen X; Wu X; Jin W; Li H; Yu C; Xiong Y; Zhou L; Chen Y
    Eur J Dermatol; 2006; 16(3):246-50. PubMed ID: 16709486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KITLG mutations cause familial progressive hyper- and hypopigmentation.
    Amyere M; Vogt T; Hoo J; Brandrup F; Bygum A; Boon L; Vikkula M
    J Invest Dermatol; 2011 Jun; 131(6):1234-9. PubMed ID: 21368769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive familial hyperpigmentation is associated with mutations activating the KIT receptor ligand].
    Dereure O
    Ann Dermatol Venereol; 2010 Mar; 137(3):247. PubMed ID: 20227574
    [No Abstract]   [Full Text] [Related]  

  • 5. De novo mutation in KITLG gene causes a variant of Familial Progressive Hyper- and Hypo-pigmentation (FPHH).
    Gorenjak M; Fijačko N; Bogomir Marko P; Živanović M; Potočnik U
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1841. PubMed ID: 34716665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation.
    Jiang X; Yang C; Wang Z; Liang L; Gong Z; Huang S; Xu Z; Zhang B; Pei X; Cai L; Wang H; Lin Z
    Br J Dermatol; 2024 Jun; 191(1):107-116. PubMed ID: 38489583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutation in the KITLG gene in familial progressive hyperpigmentation with or without hypopigmentation.
    Kato M; Yagami A; Tsukamoto T; Shinkai Y; Kato T; Kurahashi H
    J Dermatol; 2020 Jun; 47(6):669-672. PubMed ID: 32189379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Progressive Hyperpigmentation, Cutaneous Mastocytosis, and Gastrointestinal Stromal Tumor as Clinical Manifestations of Mutations in the c-KIT Receptor Gene.
    Piqueres-Zubiaurre T; Martínez de Lagrán Z; González-Pérez R; Urtaran-Ibarzabal A; Perez de Nanclares G
    Pediatr Dermatol; 2017 Jan; 34(1):84-89. PubMed ID: 27981619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial progressive hyperpigmentation: A family resurvey and ultrastructural skin investigation.
    Wang T; Li H; Dong Y; Hu M; She Q; Deng Y
    J Cutan Pathol; 2017 Nov; 44(11):948-950. PubMed ID: 28749546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel mutation in the KITLG gene in a Chinese family with familial progressive hyper- and hypopigmentation.
    Wang J; Li W; Zhou N; Liu J; Zhang S; Li X; Li Z; Yang Z; Sun M; Li M
    BMC Med Genomics; 2021 Jan; 14(1):12. PubMed ID: 33407466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease.
    Li M; Cheng R; Liang J; Yan H; Zhang H; Yang L; Li C; Jiao Q; Lu Z; He J; Ji J; Shen Z; Li C; Hao F; Yu H; Yao Z
    Am J Hum Genet; 2013 Jun; 92(6):895-903. PubMed ID: 23684010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digenic inheritance of an autosomal recessive hypotrichosis in two consanguineous pedigrees.
    Basit S; Wali A; Aziz A; Muhammad N; Jelani M; Ahmad W
    Clin Genet; 2011 Mar; 79(3):273-81. PubMed ID: 20528890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic determination of skin pigmentation: KITLG and the KITLG/c-Kit pathway as key players in the onset of human familial pigmentary diseases.
    Picardo M; Cardinali G
    J Invest Dermatol; 2011 Jun; 131(6):1182-5. PubMed ID: 21566575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial progressive hyper- and hypopigmentation and malignancy in two families with new mutations in KITLG.
    Cuell A; Bansal N; Cole T; Kaur MR; Lee J; Loffeld A; Moss C; O'Donnell M; Takeichi T; Thind CK; McGrath JA
    Clin Exp Dermatol; 2015 Dec; 40(8):860-4. PubMed ID: 26179221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EPHA2 gene is associated with cataracts linked to chromosome 1p.
    Shiels A; Bennett TM; Knopf HL; Maraini G; Li A; Jiao X; Hejtmancik JF
    Mol Vis; 2008; 14():2042-55. PubMed ID: 19005574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial progressive hyperpigmentation and hypopigmentation without KITLG mutation.
    Zeng L; Zheng XD; Liu LH; Fu LY; Zuo XB; Chen G; Wang PG; Yang S; Zhang XJ
    Clin Exp Dermatol; 2016 Dec; 41(8):927-929. PubMed ID: 27859606
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial progressive hyper- and hypopigmentation: a report on a Chinese family and evidence for genetic heterogeneity.
    Xiao-Kai F; Yue-Xi H; Yan-Jia L; Li-Rong C; He-Peng W; Qing S
    An Bras Dermatol; 2017; 92(3):329-333. PubMed ID: 29186243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial progressive hyperpigmentation: a case report.
    Yadav M; Ghonasgi S; Shah R; Meghana SM
    Case Rep Dent; 2012; 2012():840167. PubMed ID: 22577587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kindred with familial progressive hyperpigmentation-like disorder: implication of fibroblast-derived growth factors in pigmentation.
    CARDINALI G; KOVACS D; GIGLIO MD; COTA C; ASPITE N; AMANTEA A; GIROLOMONI G; PICARDO M
    Eur J Dermatol; 2009; 19(5):469-73. PubMed ID: 19505863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage of posterior amorphous corneal dystrophy to chromosome 12q21.33 and exclusion of coding region mutations in KERA, LUM, DCN, and EPYC.
    Aldave AJ; Rosenwasser GO; Yellore VS; Papp JC; Sobel EM; Pham MN; Chen MC; Dandekar S; Sripracha R; Rayner SA; Sassani JW; Gorin MB
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4006-12. PubMed ID: 20357198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.